FDA Inspection 1151796 — Levo Therapeutics, Inc.

Levo Therapeutics, Inc. — FEI 3019704412

The FDA completed an inspection of Levo Therapeutics, Inc. on August 31, 2021 in Skokie, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 31, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Skokie, IL (United States)

Additional Details

Sponsor, Contract Research Organization